Xencor, Inc. 13D and 13G filings for Zenas BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-21 4:18 pm Purchase | 2024-09-16 | 13G | Zenas BioPharma, Inc. ZBIO | Xencor Inc XNCR | 3,098,380 7.400% | 3,098,380 (New Position) | Filing |